Literature DB >> 22892192

High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients.

Katia Stankovic Stojanovic1, Olivier Steichen, Guillaume Lefevre, Claude Bachmeyer, Virginie Avellino, Gilles Grateau, Robert Girot, François Lionnet.   

Abstract

OBJECTIVES: The aim of this study is to assess biological prognostic factors at the onset of vaso-occlusive crisis (VOC) in adults with sickle cell disease (SCD).
METHODS: A monocentric prospective study including all patients admitted for VOC in a reference center for SCD was utilized. We used multivariate logistic regression to find independent predictors of severe evolution, defined by death or a worsening clinical state indicating transfusion or transfer to the intensive care unit.
RESULTS: Eighty eight patients were included, 63% were women, median age of 23 years, and 90% of patients were homozygous SCD, 10% compound heterozygous. VOC became severe in 17 patients. Patients with severe VOC were more frequently males, who also had higher white blood cell (WBC) count, procalcitonin (PCT), and lactate dehydrogenase (LDH) levels. LDH level was the best predictor of the outcome; WBC and PCT had no significant added predictive values when coupled with LDH in multivariable models, even in patients with fever or acute chest syndrome. Severe evolution always occurred when LDH levels were over 4 times the upper limit of the normal range at admission and never occurred when LDH levels were within the normal range.
CONCLUSION: Further studies should confirm the predictive value of LDH before its widespread use as a prognostic factor. If it is confirmed, the benefit of preemptive transfusion when LDH levels at admission are very high could be investigated.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892192     DOI: 10.1016/j.clinbiochem.2012.07.114

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Lactate dehydrogenase and hemolysis in sickle cell disease.

Authors:  Gregory J Kato; Seyed Mehdi Nouraie; Mark T Gladwin
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

3.  Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.

Authors:  Charles T Quinn; Eric P Smith; Shahriar Arbabi; Paramjit K Khera; Christopher J Lindsell; Omar Niss; Clinton H Joiner; Robert S Franco; Robert M Cohen
Journal:  Am J Hematol       Date:  2016-11-08       Impact factor: 10.047

Review 4.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

5.  Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.

Authors:  Tite Minga Mikobi; Prosper Lukusa Tshilobo; Michel Ntetani Aloni; Georges Mvumbi Lelo; Pierre Zalagile Akilimali; Jean Jacques Muyembe-Tamfum; Valérie Race; Gert Matthijs; Jean Marie Mbuyi Mwamba
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

6.  Pattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state.

Authors:  Juliane Almeida Moreira; Marília Rocha Laurentino; Rosângela Pinheiro Gonçalves Machado; Maritza Cavalcante Barbosa; Ronaldo Pinheiro Gonçalves; Amanda de Menezes Mota; Lilianne Brito da Silva Rocha; Alice Maria Costa Martins; Alcínia Braga de Lima Arruda; Iêda Pereira de Souza; Romélia Pinheiro Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-14

7.  Morpho-functional evaluation of lung aeration as a marker of sickle-cell acute chest syndrome severity in the ICU: a prospective cohort study.

Authors:  Marc Garnier; El Mahdi Hafiani; Charlotte Arbelot; Clarisse Blayau; Vincent Labbe; Katia Stankovic-Stojanovic; François Lionnet; Francis Bonnet; Jean-Pierre Fulgencio; Muriel Fartoukh; Christophe Quesnel
Journal:  Ann Intensive Care       Date:  2019-09-30       Impact factor: 6.925

8.  Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.

Authors:  Fouad Madhi; Annie Kamdem; Camille Jung; Adele Carlier-Gonod; Sandra Biscardi; Jeremy Busca; Cecile Arnaud; Isabelle Hau; David Narbey; Ralph Epaud; Corinne Pondarre
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

9.  Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.

Authors:  Narcisse Elenga; Gylna Loko; Maryse Etienne-Julan; Randa Al-Okka; Ahmad M Adel; Mohamed A Yassin
Journal:  Front Med (Lausanne)       Date:  2022-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.